Nashville, United States
August Bioservices is a Contract Development and Manufacturing Organization (CDMO) based in Nashville, Tennessee, specializing in offering a full range of pharmaceutical contract development and manufacturing services to pharmaceutical and biotech clients. Established in 2017, the company focuses on areas such as sterile injectables, topicals, highly-complex formulations, poorly soluble & highly viscous compounds, uncommon container sizes & fill volumes, and aseptic and non-aseptic terminally sterilized filling of vials (liquid and lyophilized), syringes, and flexible IV bags.
The company recently received a $65.00M Series B investment on 01 December 2022, with backing from Oak HC/FT and Polaris Partners. With its robust service offerings and strategic location, August Bioservices is poised to make a significant impact in the Biotechnology and Pharmaceutical industries, pointing the way for advancements in pharmaceutical development and manufacturing.
